Cargando…

Sublobar resection in the treatment of elderly patients with early-stage non-small cell lung cancer

Surgical resection is the primary treatment option for early-stage non-small cell lung cancer, lobectomy being considered the standard of care. In elderly patients, physiological characteristics can limit the suitability for surgery and the extent of resection. Sublobar resection (SLR) can be offere...

Descripción completa

Detalles Bibliográficos
Autores principales: Afonso, Margarida, Branco, Carlos, Alfaro, Tiago Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567616/
https://www.ncbi.nlm.nih.gov/pubmed/32490910
http://dx.doi.org/10.36416/1806-3756/e20190145
_version_ 1783596362699374592
author Afonso, Margarida
Branco, Carlos
Alfaro, Tiago Manuel
author_facet Afonso, Margarida
Branco, Carlos
Alfaro, Tiago Manuel
author_sort Afonso, Margarida
collection PubMed
description Surgical resection is the primary treatment option for early-stage non-small cell lung cancer, lobectomy being considered the standard of care. In elderly patients, physiological characteristics can limit the suitability for surgery and the extent of resection. Sublobar resection (SLR) can be offered as an alternative. The aim of this real-world analysis was to compare lobectomy and SLR in terms of recurrence and survival rates in patients over 70 years of age.
format Online
Article
Text
id pubmed-7567616
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sociedade Brasileira de Pneumologia e Tisiologia
record_format MEDLINE/PubMed
spelling pubmed-75676162020-10-30 Sublobar resection in the treatment of elderly patients with early-stage non-small cell lung cancer Afonso, Margarida Branco, Carlos Alfaro, Tiago Manuel J Bras Pneumol Brief Communication Surgical resection is the primary treatment option for early-stage non-small cell lung cancer, lobectomy being considered the standard of care. In elderly patients, physiological characteristics can limit the suitability for surgery and the extent of resection. Sublobar resection (SLR) can be offered as an alternative. The aim of this real-world analysis was to compare lobectomy and SLR in terms of recurrence and survival rates in patients over 70 years of age. Sociedade Brasileira de Pneumologia e Tisiologia 2020 /pmc/articles/PMC7567616/ /pubmed/32490910 http://dx.doi.org/10.36416/1806-3756/e20190145 Text en © 2020 Sociedade Brasileira de Pneumologia e Tisiologia https://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Brief Communication
Afonso, Margarida
Branco, Carlos
Alfaro, Tiago Manuel
Sublobar resection in the treatment of elderly patients with early-stage non-small cell lung cancer
title Sublobar resection in the treatment of elderly patients with early-stage non-small cell lung cancer
title_full Sublobar resection in the treatment of elderly patients with early-stage non-small cell lung cancer
title_fullStr Sublobar resection in the treatment of elderly patients with early-stage non-small cell lung cancer
title_full_unstemmed Sublobar resection in the treatment of elderly patients with early-stage non-small cell lung cancer
title_short Sublobar resection in the treatment of elderly patients with early-stage non-small cell lung cancer
title_sort sublobar resection in the treatment of elderly patients with early-stage non-small cell lung cancer
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567616/
https://www.ncbi.nlm.nih.gov/pubmed/32490910
http://dx.doi.org/10.36416/1806-3756/e20190145
work_keys_str_mv AT afonsomargarida sublobarresectioninthetreatmentofelderlypatientswithearlystagenonsmallcelllungcancer
AT brancocarlos sublobarresectioninthetreatmentofelderlypatientswithearlystagenonsmallcelllungcancer
AT alfarotiagomanuel sublobarresectioninthetreatmentofelderlypatientswithearlystagenonsmallcelllungcancer